 |
PDBsum entry 2iwu
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Chem Biol
13:1203-1215
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Inhibition of hsp90 with synthetic macrolactones: synthesis and structural and biological evaluation of ring and conformational analogs of radicicol.
|
|
N.Proisy,
S.Y.Sharp,
K.Boxall,
S.Connelly,
S.M.Roe,
C.Prodromou,
A.M.Slawin,
L.H.Pearl,
P.Workman,
C.J.Moody.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
A series of benzo-macrolactones of varying ring size and conformation has been
prepared by chemical synthesis and evaluated by structural and biological
techniques. Thus, 12- to 16-membered lactones were obtained by concise routes,
involving ring-closing metathesis as a key step. In enzyme assays, the 13-, 15-,
and 16-membered analogs are good inhibitors, suggesting that they can adopt the
required conformation to fit in the ATP-binding site. This was confirmed by
cocrystallization of 13-, 14-, and 15-membered lactones with the N-terminal
domain of yeast Hsp90, showing that they bind similarly to the
"natural" 14-membered radicicol. The most active compounds in the
ATPase assays also showed the greatest growth-inhibitory potency in HCT116 human
colon cancer cells and the established molecular signature of Hsp90 inhibition,
i.e., depletion of client proteins with upregulation of Hsp70.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Binding Interactions of Macrolactone Inhibitors
with Yeast Hsp90
|
 |
Figure 5.
Figure 5. Molecular Modeling
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Chem Biol
(2006,
13,
1203-1215)
copyright 2006.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.T.Guarnieri,
B.S.Blagg,
and
R.Zhao
(2011).
A high-throughput TNP-ATP displacement assay for screening inhibitors of ATP-binding in bacterial histidine kinases.
|
| |
Assay Drug Dev Technol,
9,
174-183.
|
 |
|
|
|
|
 |
C.Rink,
F.Sasse,
A.ZubrienÄ—,
D.Matulis,
and
M.E.Maier
(2010).
Probing the influence of an allylic methyl group in zearalenone analogues on binding to Hsp90.
|
| |
Chemistry,
16,
14469-14478.
|
 |
|
|
|
|
 |
J.E.Day,
S.Y.Sharp,
M.G.Rowlands,
W.Aherne,
P.Workman,
and
C.J.Moody
(2010).
Targeting the Hsp90 chaperone: synthesis of novel resorcylic acid macrolactone inhibitors of Hsp90.
|
| |
Chemistry,
16,
2758-2763.
|
 |
|
|
|
|
 |
J.E.Day,
S.Y.Sharp,
M.G.Rowlands,
W.Aherne,
W.Lewis,
S.M.Roe,
C.Prodromou,
L.H.Pearl,
P.Workman,
and
C.J.Moody
(2010).
Inhibition of Hsp90 with resorcylic acid macrolactones: synthesis and binding studies.
|
| |
Chemistry,
16,
10366-10372.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Ugele,
F.Sasse,
S.Knapp,
O.Fedorov,
A.Zubriene,
D.Matulis,
and
M.E.Maier
(2009).
Propionate analogues of zearalenone bind to Hsp90.
|
| |
Chembiochem,
10,
2203-2212.
|
 |
|
|
|
|
 |
S.Barluenga,
J.G.Fontaine,
C.Wang,
K.Aouadi,
R.Chen,
K.Beebe,
L.Neckers,
and
N.Winssinger
(2009).
Inhibition of HSP90 with pochoximes: SAR and structure-based insights.
|
| |
Chembiochem,
10,
2753-2759.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Li,
T.Zhang,
S.J.Schwartz,
and
D.Sun
(2009).
New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential.
|
| |
Drug Resist Updat,
12,
17-27.
|
 |
|
|
|
|
 |
S.Barluenga,
C.Wang,
J.G.Fontaine,
K.Aouadi,
K.Beebe,
S.Tsutsumi,
L.Neckers,
and
N.Winssinger
(2008).
Divergent synthesis of a pochonin library targeting HSP90 and in vivo efficacy of an identified inhibitor.
|
| |
Angew Chem Int Ed Engl,
47,
4432-4435.
|
 |
|
|
|
|
 |
T.A.Hawkins,
A.P.Haramis,
C.Etard,
C.Prodromou,
C.K.Vaughan,
R.Ashworth,
S.Ray,
M.Behra,
N.Holder,
W.S.Talbot,
L.H.Pearl,
U.Strähle,
and
S.W.Wilson
(2008).
The ATPase-dependent chaperoning activity of Hsp90a regulates thick filament formation and integration during skeletal muscle myofibrillogenesis.
|
| |
Development,
135,
1147-1156.
|
 |
|
|
|
|
 |
T.Ganesh,
J.Min,
P.Thepchatri,
Y.Du,
L.Li,
I.Lewis,
L.Wilson,
H.Fu,
G.Chiosis,
R.Dingledine,
D.Liotta,
J.P.Snyder,
and
A.Sun
(2008).
Discovery of aminoquinolines as a new class of potent inhibitors of heat shock protein 90 (Hsp90): Synthesis, biology, and molecular modeling.
|
| |
Bioorg Med Chem,
16,
6903-6910.
|
 |
|
|
|
|
 |
C.S.McErlean,
N.Proisy,
C.J.Davis,
N.A.Boland,
S.Y.Sharp,
K.Boxall,
A.M.Slawin,
P.Workman,
and
C.J.Moody
(2007).
Synthetic ansamycins prepared by a ring-expanding Claisen rearrangement. Synthesis and biological evaluation of ring and conformational analogues of the Hsp90 molecular chaperone inhibitor geldanamycin.
|
| |
Org Biomol Chem,
5,
531-546.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |